These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9062399)

  • 1. The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.
    Johnston SR; Riddler S; Haynes BP; A'Hern R; Smith IE; Jarman M; Dowsett M
    Br J Cancer; 1997; 75(6):804-9. PubMed ID: 9062399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a tamoxifen-resistant breast carcinoma xenograft.
    Naundorf H; Becker M; Lykkesfeldt AE; Elbe B; Neumann C; Büttner B; Fichtner I
    Br J Cancer; 2000 Jun; 82(11):1844-50. PubMed ID: 10839300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.
    Johnson MD; Westley BR; May FE
    Br J Cancer; 1989 May; 59(5):727-38. PubMed ID: 2736207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.
    Toi M; Harris AL; Bicknell R
    Br J Cancer; 1993 Dec; 68(6):1088-96. PubMed ID: 8260359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY; Rowlands MG; Jarman M; Kelland LR
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.
    Johnston SR; Gumbrell LA; Evans TR; Coleman RE; Smith IE; Twelves CJ; Soukop M; Rea DW; Earl HM; Howell A; Jones A; Canney P; Powles TJ; Haynes BP; Nutley B; Grimshaw R; Jarman M; Halbert GW; Brampton M; Haviland J; Dowsett M; Coombes RC;
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):341-8. PubMed ID: 14722733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular strategy to control tamoxifen resistant breast cancer.
    Jiang SY; Jordan VC
    Cancer Surv; 1992; 14():55-70. PubMed ID: 1423331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro.
    Nuttall ME; Fisher PW; Suva LJ; Gowen M
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S63-4. PubMed ID: 11056323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.
    Patel RR; Sengupta S; Kim HR; Klein-Szanto AJ; Pyle JR; Zhu F; Li T; Ross EA; Oseni S; Fargnoli J; Jordan VC
    Eur J Cancer; 2010 Jun; 46(9):1537-53. PubMed ID: 20303261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
    Borley AC; Hiscox S; Gee J; Smith C; Shaw V; Barrett-Lee P; Nicholson RI
    Breast Cancer Res; 2008; 10(6):R103. PubMed ID: 19055788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idoxifene: report of a phase I study in patients with metastatic breast cancer.
    Coombes RC; Haynes BP; Dowsett M; Quigley M; English J; Judson IR; Griggs LJ; Potter GA; McCague R; Jarman M
    Cancer Res; 1995 Mar; 55(5):1070-4. PubMed ID: 7866990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse.
    Iino Y; Wolf DM; Langan-Fahey SM; Johnson DA; Ricchio M; Thompson ME; Jordan VC
    Br J Cancer; 1991 Dec; 64(6):1019-24. PubMed ID: 1764361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?
    Wakeling AE
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):107-14. PubMed ID: 8274423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.